Pharmaceuticals

Crohn’s Disease Treatment Industry Forecast to Hit $17.34 Billion by 2029 With a Strong 7.3% CAGR

November 7, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Growth Projections For The Crohn’s Disease Treatment Market Size During 2025–2029?

The crohn’s disease treatment market size has experienced robust expansion in recent years. This market is projected to expand from $12.45 billion in 2024 to $13.1 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.2%. The historical rise in this market can be linked to factors such as a rise in disease prevalence, enhancements in diagnostic methodologies, the increasing embrace of biological therapies, greater patient understanding and educational efforts, and ongoing clinical research and development.

The market for Crohn’s disease treatment is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $17.34 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 7.3%. Several factors are contributing to this growth during the forecast period, including personalized medicine approaches, biologics market expansion, evolving treatment guidelines, increased healthcare spending, and collaborative research efforts. Key trends expected over the forecast period encompass telemedicine for patient management, research on immune modulation strategies, patient-centric care models, and the integration of digital health solutions.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10852&type=smp

What Are The Drivers Pushing New Developments In The Crohn’s Disease Treatment Market?

The increasing occurrence of inflammatory bowel disorders is projected to drive the growth of the Crohn’s disease treatment market moving forward. Inflammatory bowel disorders refer to a collection of chronic conditions marked by inflammation in the gastrointestinal tract, which can cause inflammation and damage anywhere in the digestive system, from the mouth to the anus. Treatment for Crohn’s disease functions by reducing intestinal inflammation, thereby helping to prevent symptom flare-ups and maintain remission. For instance, according to the National Center for Biotechnology Information, a US-based government organization, in September 2023, the prevalence of Crohn’s disease and ulcerative colitis showed a similar rise, with inflammatory bowel disease estimated at 825 cases per 100,000 people in 2023—comprising 410 for Crohn’s disease and 414 for ulcerative colitis and IBD-u. As a result, the escalating prevalence of these disorders is fueling the expansion of the Crohn’s disease treatment market.

Which Key Segments Fueling The Crohn’s Disease Treatment Market?

The crohn’s disease treatment market covered in this report is segmented –

1) By Drug Type: Antibiotics, Amino Salicylates, Corticosteroids, Immunomodulators, Other Drug Types

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

3) By Application: Neuropathic Pain, Fibromyalgia, Chronic Back Pain, Arthritic Pain, Migraine Post-Operative Pain, Cancer Pain, Other Applications

Subsegments:

1) By Antibiotics: Metronidazole, Ciprofloxacin, Other Antibiotics

2) By Amino Salicylates: Mesalamine, Sulfasalazine, Other Amino Salicylates

3) By Corticosteroids: Prednisone, Budesonide, Other Corticosteroids

4) By Immunomodulators: Azathioprine, Methotrexate, Mercaptopurine

5) By Other Drug Types: Biologics, Small Molecules, Other Treatments

Which Ongoing Trends Are Expected To Shape The Crohn’s Disease Treatment Market Outlook?

Companies operating within the Crohn’s disease treatment market are actively developing and gaining approval for new medications, such as biosimilar ustekinumab, with the goal of providing more effective and accessible therapeutic options for patients, thereby improving patient outcomes and overall quality of life. Biosimilar ustekinumab refers to a biological drug that shares high similarity with the original ustekinumab, a monoclonal antibody utilized for treating various autoimmune conditions. For instance, in July 2024, Sandoz International GmbH, a pharmaceutical company based in Switzerland, launched Pyzchiva (ustekinumab) across Europe. This launch marks it as the first ustekinumab biosimilar available in all strengths, including a 130 mg vial specifically designed for Crohn’s disease. This product is indicated for adults and children over six with plaque psoriasis, psoriatic arthritis, and Crohn’s disease, which enhances Sandoz’s immunology portfolio while aiming to improve access to affordable treatments for chronic inflammatory diseases.

Which Major Industry Participants Are Leading The Crohn’s Disease Treatment Market Growth?

Major companies operating in the crohn’s disease treatment market include AbbVie Inc., AstraZeneca plc, Boehringer Ingelheim GmbH, Eli Lilly and Company, Janssen Pharmaceuticals, Pfizer Inc., Takeda Pharmaceutical Company Limited, Biogen Inc., Bristol-Myers Squibb Company, Galapagos NV, Novartis AG, Sanofi S.A., F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., Mylan N.V., Glenmark Pharmaceuticals, Tillotts Pharma AG, Dr. Falk Pharma GmbH, Shire Pharmaceuticals, Salix Pharmaceuticals, Prometheus Laboratories Inc., Arena Pharmaceuticals Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/crohns-disease-treatment-global-market-report

What Are The Key Regional Factors Influencing The Crohn’s Disease Treatment Market Growth?

North America was the largest region in the global Crohn’s disease treatment market in 2024 and is expected to be the fastest-growing region in the forecast period. The regions covered in the Crohn’s disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Crohn’s Disease Treatment Market Report:

https://www.thebusinessresearchcompany.com/customise?id=10852&type=smp

Browse Through More Reports Similar to the Global Crohn’s Disease Treatment Market 2025, By The Business Research Company

Alzheimer Disease Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/alzheimer-disease-treatment-global-market-report

Autoimmune Disease Diagnosis Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-global-market-report

Enteric Disease Testing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/enteric-disease-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795